Suppr超能文献

VDAC1-NF-κB/p65介导的S100A16通过钙调蛋白/CaMKK2/AMPK途径调节氧化应激和炎症反应,从而导致心肌缺血/再灌注损伤。

VDAC1-NF-κB/p65-mediated S100A16 contributes to myocardial ischemia/reperfusion injury by regulating oxidative stress and inflammatory response via calmodulin/CaMKK2/AMPK pathway.

作者信息

Zi Congna, Ma Xian, Zheng Maodong, Zhu Ying

机构信息

Department of Anesthesiology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China.

Department of Blood Transfusion, The First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China.

出版信息

Eur J Pharmacol. 2025 Jan 15;987:177158. doi: 10.1016/j.ejphar.2024.177158. Epub 2024 Nov 28.

Abstract

Myocardial injury triggers intense inflammatory reactions and oxidative stress responses. S100 calcium-binding protein A16 (S100A16), a multi-functional calcium (Ca)-binding protein, participates in inflammatory responses and contributes to ischemia/reperfusion (I/R) injury. Nevertheless, the precise mechanism by which S100A16 operates in myocardial I/R injury remains uncertain. Cardiac I/R injury was produced by ligation/release of the left anterior descending artery, and mouse cardiac cells were subjected to hypoxia/reoxygenation (H/R) to determine the biological effects in vitro. We demonstrated that S100A16 was upregulated in the ischemic hearts and cardiac cells after I/R and H/R injury. Adenovirus-mediated S100A16 inhibition led to a considerable improvement in cardiac function with a reduced infarct size, accompanied by a reduction in cardiomyocyte apoptosis. Similar effects of S100A16 inhibition on inflammation and reactive oxygen species (ROS) production were observed in cultured cardiomyocytes. Importantly, we showed that I/R and H/R treatment upregulated the expression of voltage-dependent anion channel 1 (VDAC1), which subsequently activated NF-κB/p65 to facilitate the binding of NF-κB/p65 to the S100A16 promoter, thereby activating the transcription and expression of S100A16. Mechanically, S100A16 responded to increasing Ca and interacted with calmodulin (CaM) to regulate the activation of calcium/calmodulin-dependent protein kinase 2 (CAMKK2)/AMPK pathway. In conclusion, VDAC1 sustained the NF-κB p65 pathway activation to elicit increased S100A16 expression, contributing to myocardial damage and heart failure post-I/R via the CaM/CaMKK2/AMPK pathway. This study revealed a crucial role of the VDAC1-S100A16 axis in the process of myocardial I/R injury, providing novel molecular targets for the treatment of cardiac conditions associated with I/R injury.

摘要

心肌损伤会引发强烈的炎症反应和氧化应激反应。S100钙结合蛋白A16(S100A16)是一种多功能钙结合蛋白,参与炎症反应并导致缺血/再灌注(I/R)损伤。然而,S100A16在心肌I/R损伤中发挥作用的确切机制仍不确定。通过结扎/松开左前降支动脉制造心脏I/R损伤,并对小鼠心脏细胞进行缺氧/复氧(H/R)处理以确定体外生物学效应。我们证明,在I/R和H/R损伤后,缺血心脏和心脏细胞中的S100A16表达上调。腺病毒介导的S100A16抑制导致心脏功能显著改善,梗死面积减小,同时心肌细胞凋亡减少。在培养的心肌细胞中也观察到S100A16抑制对炎症和活性氧(ROS)产生的类似作用。重要的是,我们发现I/R和H/R处理上调了电压依赖性阴离子通道1(VDAC1)的表达,随后激活NF-κB/p65以促进NF-κB/p65与S100A16启动子的结合,从而激活S100A16的转录和表达。机制上,S100A16对增加的钙做出反应,并与钙调蛋白(CaM)相互作用以调节钙/钙调蛋白依赖性蛋白激酶2(CAMKK2)/AMPK途径的激活。总之,VDAC1维持NF-κB p65途径的激活以引发S100A16表达增加,通过CaM/CaMKK2/AMPK途径导致I/R后的心肌损伤和心力衰竭。本研究揭示了VDAC1-S100A16轴在心肌I/R损伤过程中的关键作用,为治疗与I/R损伤相关的心脏疾病提供了新的分子靶点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验